BRCA1 and ovarian cancer: Our results show that the addition of confirmed predisposition genes for breast and ovarian cancer almost doubles the diagnostic yield as compared with testing only for BRCA1 and BRCA2. The preliminary results of this study have already informed national guidelines for cancer care.